Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 2
2003 1
2007 3
2008 4
2009 10
2010 10
2011 15
2012 22
2013 14
2014 27
2015 34
2016 19
2017 38
2018 42
2019 57
2020 54
2021 66
2022 57
2023 57
2024 71

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

541 results

Results by year

Filters applied: . Clear all
Page 1
Mechanosensitive TRPV4 is required for crystal-induced inflammation.
Lan Z, Chen L, Feng J, Xie Z, Liu Z, Wang F, Liu P, Yue X, Du L, Zhao Y, Yang P, Luo J, Zhu Z, Hu X, Cao L, Lu P, Sah R, Lavine K, Kim B, Hu H. Lan Z, et al. Among authors: cao l. Ann Rheum Dis. 2021 Dec;80(12):1604-1614. doi: 10.1136/annrheumdis-2021-220295. Epub 2021 Oct 18. Ann Rheum Dis. 2021. PMID: 34663597 Free PMC article.
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Hassan R, Butler M, O'Cearbhaill RE, Oh DY, Johnson M, Zikaras K, Smalley M, Ross M, Tanyi JL, Ghafoor A, Shah NN, Saboury B, Cao L, Quintás-Cardama A, Hong D. Hassan R, et al. Among authors: cao l. Nat Med. 2023 Aug;29(8):2099-2109. doi: 10.1038/s41591-023-02452-y. Epub 2023 Jul 27. Nat Med. 2023. PMID: 37501016 Free PMC article. Clinical Trial.
Immunotherapy for gastric cancer: dilemmas and prospect.
Zhao Q, Cao L, Guan L, Bie L, Wang S, Xie B, Chen X, Shen X, Cao F. Zhao Q, et al. Among authors: cao l. Brief Funct Genomics. 2019 Mar 22;18(2):107-112. doi: 10.1093/bfgp/ely019. Brief Funct Genomics. 2019. PMID: 30388190 Review.
A rare case of massive myxoma.
Liang C, Feng L, Shunlin G. Liang C, et al. Asian J Surg. 2024 Apr;47(4):1785-1786. doi: 10.1016/j.asjsur.2023.12.117. Epub 2023 Dec 29. Asian J Surg. 2024. PMID: 38160155 Free article. No abstract available.
Anti-cancer effect of toosendanin and its underlying mechanisms.
Zhang S, Cao L, Wang ZR, Li Z, Ma J. Zhang S, et al. Among authors: cao l. J Asian Nat Prod Res. 2019 Mar;21(3):270-283. doi: 10.1080/10286020.2018.1451516. Epub 2018 Apr 9. J Asian Nat Prod Res. 2019. PMID: 29629572 Review.
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
Mansfield AS, Vivien Yin J, Bradbury P, Kwiatkowski DJ, Patel S, Bazhenova LA, Forde P, Lou Y, Dizona P, Villaruz LC, Arnold SM, Khalil M, Kindler HL, Koczywas M, Pacheco J, Rolfo C, Xia B, Mikula E, Chen L, Patel K, Smith KER, Cao L, Shapiro G, Costello BA, Adjei A, Sharon E, Moscow JA, Zamboni W, Hassan R. Mansfield AS, et al. Among authors: cao l. Lung Cancer. 2024 Sep;195:107928. doi: 10.1016/j.lungcan.2024.107928. Epub 2024 Aug 13. Lung Cancer. 2024. PMID: 39197359 Clinical Trial.
Atom-glue stabilized Pt-based intermetallic nanoparticles.
Huang Z, Wang Y, Xia J, Hu S, Chen N, Ding T, Zhan C, Pao CW, Hu Z, Huang WH, Shi T, Meng X, Xu Y, Cao L, Huang X. Huang Z, et al. Among authors: cao l. Sci Adv. 2024 Oct 4;10(40):eadq6727. doi: 10.1126/sciadv.adq6727. Epub 2024 Oct 4. Sci Adv. 2024. PMID: 39365856 Free PMC article.
541 results